4//SEC Filing
ROSA-BJORKESON DAGMAR 4
Accession 0001104659-21-075217
CIK 0001270073other
Filed
May 31, 8:00 PM ET
Accepted
Jun 1, 7:01 PM ET
Size
7.7 KB
Accession
0001104659-21-075217
Insider Transaction Report
Form 4
ROSA-BJORKESON DAGMAR
Director
Transactions
- Award
Option to Purchase Common Stock
2021-05-27+17,719→ 17,719 totalExercise: $17.08Exp: 2031-05-27→ Common Stock (17,719 underlying) - Award
Common Stock
2021-05-27+10,543→ 10,543 total
Footnotes (2)
- [F1]Represents restricted stock units granted to the Reporting Person. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock. 1/3rd of the shares subject to the award shall vest on each anniversary of the Vesting Commencement Date (or, if earlier in any given year, the day immediately preceding the date of the Issuer's Annual Meeting of Stockholders in such year). The Vesting Commencement Date is April 1, 2021.
- [F2]1/3rd of the options subject to the award shall vest and become exercisable on each anniversary of the Vesting Commencement Date (or, if earlier in any given year, the day immediately preceding the date of the Issuer's Annual Meeting of Stockholders in such year). The Vesting Commencement Date is April 1, 2021.
Documents
Issuer
INTERCEPT PHARMACEUTICALS, INC.
CIK 0001270073
Entity typeother
Related Parties
1- filerCIK 0001643934
Filing Metadata
- Form type
- 4
- Filed
- May 31, 8:00 PM ET
- Accepted
- Jun 1, 7:01 PM ET
- Size
- 7.7 KB